protein

VEGF165 Protein, Human (HEK293)

HY-P7110A

2 μg;10 μg;20 μg;50 μg;100 μg

60;160;230;410;680 USD

VEGF165 Protein, Human (HEK293)

proteins

HEK293

2 μg;10 μg;20 μg;50 μg;100 μg

60;160;230;410;680 USD

375588583

VEGF165 Protein, Human (HEK293) is a Vascular Endothelial Growth Factor A (VEGF-A) isoform. VEGF is a heparin-binding growth factor specific for vascular endothelial cells that is able to induce angiogenesis.

Human

Vascular Endothelial Growth Factor (VEGF) has multiple isoforms, created by alternative splicing or proteolytic cleavage, and characterized by different receptor-binding and matrix-binding properties. These isoforms are known to give rise to a spectrum of angiogenesis patterns marked by differences in branching, which has functional implications for tissues. VEGF-A is a key member of the VEGF family of cytokines, along with VEGF-B, -C, -D, and PlGF. VEGF-A mediates angiogenesis, the expansion of an existing vascular bed by sprouting of new blood vessels. The vegfa gene is translated into a number of splice isoforms, the most notable in humans being VEGF121, VEGF165, and VEGF189 [1] .

VEGF-AA; rHuVEGF165; VPF; Folliculostellate cell-derived growth factor; Glioma-derived endothelial cell mitogen

Greater than 95% as determined by reducing SDS-PAGE.

Lyophilized from a 0.2 μm filtered solution of PBS or 20mM Citrate, 8% Sucrose, 4% Mannitol, 0.05% Tween 80, pH 4.0 or 50 mM PB, 300 mM NaCl, pH 7.4 or PBS, pH 7.4, 5% trehalose, 5% mannitol and 0.01% Tween80 or PBS, pH 7.4, 8% trehalose or 20 mM Tris, 150 mM NaCl, pH 8, 5% Trehalose, 5% Mannitol, 0.01% Tween-80.

Room temperature in continental US; may vary elsewhere.